{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T00:05:40Z","timestamp":1758931540090,"version":"3.44.0"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Introduction and importance:<\/jats:title>\n            <jats:p>Cyclophosphamide is a widely used immunosuppressant for inducing remission in various immune-mediated conditions. However, its potential for cardiotoxicity is well documented. One of the earliest possible manifestations of this cardiotoxicity following cyclophosphamide infusion is atrial fibrillation (AF), which typically presents within 48\u00a0h of the infusion.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Case presentation:<\/jats:title>\n            <jats:p>The authors present a case of a 58-year-old male with anti-neutrophil cytoplasmic antibodies (ANCA)-associated vasculitis who presented to the emergency department with clinical features of acute kidney injury. Following subsequent assessment and evaluation, the patient was managed in the intensive care unit with hemodialysis and intravenous corticosteroids. He was aimed at inducing remission with cyclophosphamide infusion. However, a few hours following induction with cyclophosphamide infusion, the patient developed palpitation, sweating, and tachycardia with a heart rate of 140\u2013180\/min. The electrocardiogram showed an irregular QRS complex with an absent p-wave. AF was diagnosed and managed with amiodarone infusion for 24\u00a0h followed by oral maintenance dosing. No further episode of AF occurred following cessation of cyclophosphamide and switching to rituximab for the treatment of ANCA-associated vasculitis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Clinical discussion:<\/jats:title>\n            <jats:p>Cyclophosphamide, even at lower dosages, can cause cardiotoxicity in patients with renal impairment due to the delayed elimination of its toxic metabolites. In addition, patients who receive CYP 450 inducers, such as prednisone, may experience the accelerated build-up of its toxic metabolites, thereby raising the risk for cardiotoxicity.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>The cardiotoxic manifestation of cyclophosphamide can arise from its use in several immune-mediated conditions. Given its potential for cardiotoxicity, careful cardiac monitoring during and after cyclophosphamide infusion is essential to ensure timely intervention, if needed.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/ms9.0000000000002809","type":"journal-article","created":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T13:51:21Z","timestamp":1734616281000},"page":"376-379","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Cyclophosphamide-induced atrial fibrillation in the context of ANCA-associated vasculitis: a case report"],"prefix":"10.1097","volume":"87","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-9367-7994","authenticated-orcid":false,"given":"Sakar","family":"Pandey","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Kathmandu University School of Medical Sciences, Dhulikhel, Nepal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aayusha","family":"Dhakal","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Kathmandu University School of Medical Sciences, Dhulikhel, Nepal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roshan","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Kathmandu University School of Medical Sciences, Dhulikhel, Nepal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rahul","family":"Shakya","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Nepalgunj Medical College, Nepalgunj, Nepal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sweta","family":"Dhakal","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Lyceum-Northwestern University, Manila, Philippines"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sagar","family":"Bhandari","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, SUNY Downstate, Brooklyn, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,1]]},"reference":[{"key":"R1-20250926","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1056\/NEJM197208102870606","article-title":"Immunosuppressive therapy: (second of two parts)","volume":"287","author":"Skinner","year":"1972","journal-title":"N Engl J Med"},{"key":"R2-20250926","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nrrheum.2014.103","article-title":"Pathogenesis of antineutrophil cytoplasmic autoantibody-mediated disease","volume":"10","author":"Jennette","year":"2014","journal-title":"Nat Rev Rheumatol"},{"key":"R3-20250926","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1182\/blood.V41.2.273.273","article-title":"Mechanisms of immunosuppression: effects of cyclophosphamide on cellular immunity","volume":"41","author":"Winkelstein","year":"1973","journal-title":"Blood"},{"key":"R4-20250926","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.autrev.2012.11.012","article-title":"Standard immunosuppressive therapy of immune-mediated glomerular diseases","volume":"12","author":"Pani","year":"2013","journal-title":"Autoimmun Rev"},{"key":"R5-20250926","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1161\/CIRCEP.107.754564","article-title":"Atrial remodeling and atrial fibrillation: mechanisms and implications","volume":"1","author":"Nattel","year":"2008","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"R6-20250926","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1093\/rheumatology\/kex338","article-title":"Cardiovascular events in anti-neutrophil cytoplasmic antibody-associated vasculitis: a meta-analysis of observational studies","volume":"57","author":"Houben","year":"2018","journal-title":"Rheumatology"},{"key":"R7-20250926","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S1083-8791(00)70043-7","article-title":"Cardiac toxicity following high-dose cyclophosphamide, cisplatin, and BCNU (STAMP-I) for breast cancer","volume":"6","author":"Nieto","year":"2000","journal-title":"Biology of Blood and Marrow Transplantation"},{"key":"R8-20250926","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/nrclinonc.2009.146","article-title":"Cyclophosphamide and cancer: golden anniversary","volume":"6","author":"Emadi","year":"2009","journal-title":"Nat Rev Clin Oncol"},{"key":"R9-20250926","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S0140-6736(00)02051-1","article-title":"QT dispersion as a predictor of acute heart failure after high-dose cyclophosphamide","volume":"355","author":"Nakamae","year":"2000","journal-title":"Lancet"},{"key":"R10-20250926","first-page":"e2633","article-title":"Cyclophosphamide-induced atrial fibrillation with rapid ventricular rate","volume":"10","author":"Ejaz","year":"2018","journal-title":"Cureus"},{"key":"R11-20250926","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.lfs.2018.12.018","article-title":"Molecular mechanism involved in cyclophosphamide-induced cardiotoxicity: old drug with a new vision","volume":"218","author":"Iqubal","year":"2019","journal-title":"Life Sci"},{"key":"R12-20250926","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1182\/blood.V68.5.1114.1114","article-title":"Cyclophosphamide cardiotoxicity: an analysis of dosing as a risk factor","volume":"68","author":"Goldberg","year":"1986","journal-title":"Blood"},{"key":"R13-20250926","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/sj.bmt.1702234","article-title":"Cardiac and pulmonary toxicity in patients undergoing high-dose chemotherapy for lymphoma and breast cancer: prognostic factors","volume":"25","author":"Brockstein","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"R14-20250926","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1161\/CIRCIMAGING.110.960500","article-title":"Prognostic value and determinants of a hypointense infarct core in T2-weighted cardiac magnetic resonance in acute reperfused ST-elevation\u2013myocardial infarction","volume":"4","author":"Eitel","year":"2011","journal-title":"Circ Cardiovasc Imaging"},{"key":"R15-20250926","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1056\/NEJM199205073261906","article-title":"Management of atrial fibrillation","volume":"326","author":"Wood","year":"1992","journal-title":"N Engl J Med"}],"container-title":["Annals of Medicine &amp; Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MS9.0000000000002809","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T08:00:54Z","timestamp":1758873654000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MS9.0000000000002809"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":15,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/ms9.0000000000002809","relation":{},"ISSN":["2049-0801"],"issn-type":[{"type":"electronic","value":"2049-0801"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"2024-07-10","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-20","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}